In 2023, with the rapid development of the Chinese economy, the country’s investment in the healthcare industry has significantly increased, and the development of the healthcare industry is thriving. Due to China’s good brand reputation in the international market and the continuous improvement of medical technology, pharmaceutical and healthcare products have become the preferred products in many countries around the world. Regarding the overview of China’s pharmaceutical foreign trade import and export in 2023, the analysis and statistics are as follows:

 

1、 The total import and export volume of China’s pharmaceutical foreign trade in 2023:

 

In 2023, the total import and export volume of China’s pharmaceutical industry will reach 80 billion US dollars, an increase of 25% compared to 2018. Among them, the export amount reached 50 billion US dollars, an increase of 18.5% over the previous year; The import amount reached 30 billion US dollars, an increase of 15% over the previous year.

 

2、 Composition of Import and Export Commodities in China’s Pharmaceutical Industry in 2023:

 

1. Import: China’s imported medical and health products mainly come from developed countries in Europe and America, including antibiotics, chemical drugs, anti tuberculosis drugs, etc. In addition, with the continuous improvement of China’s pharmaceutical industry and national drug policies, most imported drugs must undergo strict approval before entering the Chinese market.

 

2. Export: With the reduction of production costs in Chinese factories and the improvement of clinical trial quality, China has become the world’s largest producer, exporting products to dozens of countries and regions around the world, mainly including antibiotics, biological products, and Western medicine.

 

3、 The largest export market for Chinese pharmaceutical and healthcare products in 2023:

 

According to statistics, the top five pharmaceutical exports from China in 2023 are the United States, Japan, South Korea, Southeast Asian countries, and European countries. Among them, the North American market led by the United States and the Asian market led by Japan will be the largest export markets for Chinese pharmaceutical products in 2023.

 

4、 Development Trends of China’s Pharmaceutical Import and Export Industry in 2023:

 

Research shows that with the integration of China’s foreign trade market and the innovation of enterprise management strategies, the Chinese pharmaceutical import and export industry will continue to show rapid growth in 2023. The export of pharmaceutical and health products, including biological products, will grow rapidly. Similarly, China’s pharmaceutical imports will also achieve high-speed growth. It is expected that by 2023, the total volume of China’s pharmaceutical imports and exports will reach a historical high.